Difference between revisions of "Category:Mutation-specific medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 1: Line 1:
 
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific mutations. To be expanded.
 
Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific mutations. To be expanded.
  
[[Category:Drug index]]
+
[[Category:Biomarker-specific medications]]

Revision as of 23:00, 26 October 2017

Drugs with an FDA indication for effectiveness (or lack of efficacy) in the context of one or more specific mutations. To be expanded.

Pages in category "Mutation-specific medications"

The following 69 pages are in this category, out of 69 total.